# L-citrulline and Metformin in Becker's Muscular Dystrophy

> **NCT02018731** · PHASE2 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 20 (actual)

## Conditions studied

- Becker's Muscular Dystrophy (BMD)

## Interventions

- **DRUG:** Metformin and Metformin & L-Citrulline
- **DRUG:** L-Citrulline and Metformin & L-Citrulline

## Key facts

- **NCT ID:** NCT02018731
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-09
- **Final completion:** 2015-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02018731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02018731, "L-citrulline and Metformin in Becker's Muscular Dystrophy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02018731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*